Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $193M | $191M | $251M | $506M | $583M | $538M | $405M | $453M | $532M | $554M |
| Revenue growth | — | -1.4% | 31.8% | 101.4% | 15.1% | -7.6% | -24.7% | 11.7% | 17.6% | 4.1% |
| Gross profit | — | — | — | — | — | — | — | $159M | $208M | $241M |
| Gross margin | — | — | — | — | — | — | — | 35.2% | 39.2% | 43.5% |
| Operating income | $2.82M | -$9.45M | $2.55M | $81.4M | $53.3M | -$126M | -$103M | -$29.1M | $23.6M | $66.5M |
| Operating margin | 1.5% | -5.0% | 1.0% | 16.1% | 9.1% | -23.3% | -25.3% | -6.4% | 4.4% | 12.0% |
| Net income | $304K | $25.4M | $241K | $66.9M | $45.5M | -$104M | -$88.7M | -$28.2M | $10.1M | $40.0M |
| Net margin | 0.2% | 13.3% | 0.1% | 13.2% | 7.8% | -19.4% | -21.9% | -6.2% | 1.9% | 7.2% |
| EPS (diluted) | $0.02 | $1.33 | $0.01 | $2.73 | $1.68 | -$4.59 | -$4.36 | -$2.37 | -$1.19 | -$0.34 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $4.08M | -$15.5M | -$3.23M | -$71.5M | -$108M | -$163M | -$26.9M | -$6.69M | -$18.4M | -$25.3M |
| Capital expenditures | $1.89M | $1.87M | $4.53M | $6.64M | $7.75M | $3.87M | $214K | $2.09M | $2.09M | $2.25M |
| Free cash flow | $2.19M | -$17.4M | -$7.76M | -$78.1M | -$116M | -$166M | -$27.1M | -$8.78M | -$20.5M | -$27.6M |
| Share buybacks | $0.00 | — | — | — | — | — | — | — | — | — |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $61.8M | $40.3M | $13.1M | $23.5M | $43.8M | $81.9M | $144M | $116M | $39.2M | $73.7M |
| Total assets | $109M | $359M | $439M | $742M | $1.04B | $1.15B | $1.11B | $1.11B | $1.16B | $1.26B |
| Total liabilities | — | — | — | — | $202M | $167M | $198M | $209M | $229M | $289M |
| Long-term debt | — | $0.00 | $5.00M | $0.00 | — | $0.00 | $66.1M | $67.8M | $68.5M | $113M |
| Shareholders' equity | $252M | $287M | $303M | $527M | $838M | $750M | $651M | $606M | $588M | $592M |
| Retained earnings | $4.62M | $205M | $205M | $272M | $316M | $193M | $73.8M | $7.28M | $15.2M | $30.1M |
| Shares (wtd avg diluted) | 18.3M | 19.0M | 20.4M | 24.5M | 27.0M | 26.8M | 27.4M | 28.0M | 29.3M | 30.5M |
Every figure is extracted from eHealth, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.